These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 2151685

  • 1. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR, Frey J, Takeshita T, Sugamura K.
    Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
    [Abstract] [Full Text] [Related]

  • 2. Role of CD2 in regulation of CD3- LGL function.
    Mason A, Bernard A, Smyth MJ, Ortaldo JR.
    Eur Cytokine Netw; 1991; 2(1):31-7. PubMed ID: 1714784
    [Abstract] [Full Text] [Related]

  • 3. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
    Ortaldo JR, Mason AT, O'Shea JJ, Smyth MJ, Falk LA, Kennedy IC, Longo DL, Ruscetti FW.
    J Immunol; 1991 Jun 01; 146(11):3791-8. PubMed ID: 1851793
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B, Gately M, Espevik T.
    J Immunol; 1992 Apr 15; 148(8):2429-36. PubMed ID: 1373169
    [Abstract] [Full Text] [Related]

  • 5. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM.
    Cancer Res; 1990 May 01; 50(9):2683-91. PubMed ID: 1691679
    [Abstract] [Full Text] [Related]

  • 6. Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation.
    Novelli F, Giovarelli M, Reber-Liske R, Virgallita G, Garotta G, Forni G.
    J Immunol; 1991 Aug 15; 147(4):1445-52. PubMed ID: 1831225
    [Abstract] [Full Text] [Related]

  • 7. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 15; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 8. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
    Conlon KC, Ochoa AC, Kopp WC, Ortaldo JR, Urba WJ, Longo DL, Young HA.
    J Immunol; 1992 Nov 15; 149(10):3278-89. PubMed ID: 1358968
    [Abstract] [Full Text] [Related]

  • 9. Modulation of CD3- large granular lymphocyte functions by agonist and antagonists of protein kinase C: effects on NK and lymphokine-activated killer activity and production of IFN-gamma.
    Ortaldo JR, Young HA, Varesio L.
    J Immunol; 1989 Jul 01; 143(1):366-71. PubMed ID: 2543702
    [Abstract] [Full Text] [Related]

  • 10. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH.
    Anticancer Res; 1992 Jul 01; 12(6B):1925-33. PubMed ID: 1295440
    [Abstract] [Full Text] [Related]

  • 11. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A, Bell GI, Director EP.
    J Immunol; 1988 Jul 15; 141(2):690-8. PubMed ID: 3133414
    [Abstract] [Full Text] [Related]

  • 12. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.
    Eur J Immunol; 1992 Jan 15; 22(1):1-6. PubMed ID: 1370410
    [Abstract] [Full Text] [Related]

  • 13. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Strieter RM, Kunkel SL.
    Invest Ophthalmol Vis Sci; 1997 Feb 15; 38(2):446-55. PubMed ID: 9040478
    [Abstract] [Full Text] [Related]

  • 14. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM, Zhu HG, Anderer FA.
    Anticancer Res; 1993 Feb 15; 13(4):923-30. PubMed ID: 8352560
    [Abstract] [Full Text] [Related]

  • 15. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 16. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M, Santoni A, Jemma C, Musso T, Giuffrida AM, Cavallo G, Landolfo S, Forni G.
    J Immunol; 1988 Oct 15; 141(8):2831-6. PubMed ID: 3139768
    [Abstract] [Full Text] [Related]

  • 17. CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes.
    Faure F, Jitsukawa S, Triebel F, Hercend T.
    J Immunol; 1988 Mar 01; 140(5):1372-9. PubMed ID: 2964471
    [Abstract] [Full Text] [Related]

  • 18. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
    Carson WE, Fehniger TA, Caligiuri MA.
    Eur J Immunol; 1997 Feb 01; 27(2):354-60. PubMed ID: 9045904
    [Abstract] [Full Text] [Related]

  • 19. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL.
    J Immunol; 1992 Jul 01; 149(1):340-9. PubMed ID: 1535088
    [Abstract] [Full Text] [Related]

  • 20. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E.
    Int Immunol; 2009 Feb 01; 21(2):145-53. PubMed ID: 19088061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.